News & AnalysisTheseus Pharmaceuticals picks up $100m Series BTheseus Pharmaceuticals, a biotechnology company, has raised $100 million in Series B financing.ByIris Dorbian13 April 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs